Cork-based supplements group raises €6.7m for expansion

Solvotrin Therapeutics, headquartered in Little Island, is now valued at €45m

Cork-based supplements group, Solvotrin Therapeutics, has secured €6.7m in funding. Pictured are Solvotrin leadership team Ronan McClafferty, Chief Operating Officer; Pat O'Flynn, CEO; and George Walsh, Chief Financial Officer. 

A Cork-based supplements group has raised €6.7 million in its latest funding round.

Solvotrin Therapeutics, which manufactures a number of ‘active iron’ products, is now valued at €45 million.